Who owns Royalty Pharma plc (RPRX)? Elite investor 13F holders
7 tracked elite investors reported holding Royalty Pharma plc as of 2026-06-30, including Patient Capital Management, Dorsey Asset Management, Renaissance Technologies LLC, D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Patient Capital Management | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 201785166.00 USD | 3598808.000000 | Shares | reduce | Original filing |
| Dorsey Asset Management | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 137737525.00 USD | 2456528.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 108540306.00 USD | 1935800.000000 | Shares | add | Original filing |
| D.E. Shaw | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 29443142.00 USD | 525114.000000 | Shares | reduce | Original filing |
| Tudor Investment | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 34243968.00 USD | 610736.000000 | Shares | reduce | Original filing |
| Torray Funds | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 33755710.00 USD | 602028.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12317850.00 USD | 219687.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.